| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.6M | +756.4% |
| Cost of Revenue | $5.3M | +423.1% |
| Gross Profit | $8.3M | +1329.5% |
| R&D Expense | $2.5M | +2.9% |
| SG&A Expense | $9.2M | +4.4% |
| Operating Income | -$56.5M | -372.7% |
| Pre-tax Income | -$62.0M | -184.4% |
| Income Tax | -$106K | — |
| Net Income | -$61.9M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.8M | +483.0% |
| Accounts Receivable | $2.8M | +7.4% |
| Inventory | $3.0M | +33.8% |
| Current Assets | $30.3M | +286.2% |
| Total Assets | $54.3M | +411.0% |
| Current Liabilities | $7.3M | +45.3% |
| Long-term Debt | $13.3M | +0.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.4M | -47.7% |
| Capital Expenditures | $352K | +105.8% |
| Investing Cash Flow | $1.9M | +1184.8% |
| Financing Cash Flow | $33.3M | +7644.0% |
| Free Cash Flow | -$15.7M | -48.6% |
| -402.1% |
| EPS (Basic) | -$5.00 | +9.7% |
| EPS (Diluted) | -$5.00 | +9.7% |
| Total Liabilities |
| $8.2M |
| +37.5% |
| Stockholders' Equity | $46.1M | +887.6% |